Vaginal symptoms in postmenopausal women: Self-reported severity, natural history, and risk factors

Menopause

Volumn 17, Issue 1, 2010, Pages 121-126

  Huang, Alison J ^a   Moore, Elya E ^b   Boyko, Edward J ^c,d   Scholes, Delia ^e   Lin, Feng ^a   Vittinghoff, Eric ^a   Fihn, Stephan D ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF WASHINGTON   (United States)

^d VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^e CENTER FOR HEALTH STUDIES   (United States)

^f DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Dyspareunia; Menopause; Sexual dysfunction.; Vaginal atrophy; Vaginal dryness

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; ESTROGEN DEFICIENCY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MICROFLORA; POSTMENOPAUSE; SCORING SYSTEM; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; STRUCTURED QUESTIONNAIRE; VAGINAL DRYNESS; VAGINAL PRURITUS;

AGE FACTORS; AGED; BODY MASS INDEX; DIABETES MELLITUS; DYSPAREUNIA; FEMALE; HEALTH SURVEYS; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; ODDS RATIO; POSTMENOPAUSE; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VAGINAL DISEASES; WASHINGTON;

EID: 74549172492     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181acb9ed     Document Type: Article

References (23)

1. Society of Obstetricians and Gynaecologists of Canada. SOGC clinical practice guidelines. The detection and management of vaginal atrophy. Number 145, May 2004. Int J Gynaecol Obstet 2005;88:222-228.
2. Gorodeski GI. Effects of estrogen on proton secretion via the apical membrane in vaginal-ectocervical epithelial cells of postmenopausal women. Menopause 2005;12:679-684.
3. Pabich WL, Fihn SD, Stamm WE, Scholes D, Boyko EJ, Gupta K. Prevalence and determinants of vaginal flora alterations in postmeno-pausal women. J Infect Dis 2003;188:1054-1058.
4. Van Voorhis BJ. Genitourinary symptoms in the menopausal transition. Am J Med 2005;118:47-53.
5. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96:351-358.
6. Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives. Am J Med 2005;118:14-24.
7. Huang AJ, Grady D, Jacoby VL, Blackwell TL, Bauer DC, Sawaya GF. Persistent hot flushes in older postmenopausal women. Arch Intern Med 2008;168:840-846.
8. Stone SC, Mickal A, Rye PH. Postmenopausal symptomatology, maturation index, and plasma estrogen levels. Obstet Gynecol 1975; 45:625-627.
9. Jackson SL, Boyko EJ, Scholes D, Abraham L, Gupta K, Fihn SD. Predictors of urinary tract infection after menopause: a prospective study. Am J Med 2004;117:903-911.
10. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473-483.
11. 2-producing lactobacilli, and bacterial vagi-nosis in pregnant women. Clin Infect Dis 1993;16:S273-S281.
12. Balows A, Hauser W, Herrmann K, Isenberg H, Shadomy H. Manual of Clinical Microbiology, 5th ed. Washington, DC: American Society for Microbiology, 1991.
13. Horvitz D, Thompson D. A generalization of sampling without replacement from a finite universe. J Am Stat Assoc 1952;47:663-685.
14. Vittinghoff E, Glidden D, Shiboski S, McCulloch C. Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models. New York: Springer, 2005.
15. Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 1989;129:1120-1131.
16. Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000;152:463-473.
17. Avellanet YR, Ortiz AP, Pando JR, Romaguera J. Dyspareunia in Puerto Rican middle-aged women. Menopause 2009;16:742-747.
18. Davila GW, Singh A, Karapanagiotou I, et al. Are women with urogenital atrophy symptomatic? Am J Obstet Gynecol 2003;188: 382-388.
19. Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2003;4: CD001500.
20. Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1998;92:722-727.
21. Pastore LM, Carter RA, Hulka BS, Wells E. Self-reported urogenital symptoms in postmenopausal women: Women's Health Initiative. Maturitas 2004;49:292-303.
22. Stenberg A, Heimer G, Ulmsten U, Cnattingius S. Prevalence of genitourinary and other climacteric symptoms in 61-year-old women. Maturitas 1996;24:31-36.
23. Barlow DH, Cardozo LD, Francis RM, et al. Urogenital ageing and its effect on sexual health in older British women. Br J Obstet Gynaecol 1997;104:87-91.